Keep shopping
0
Your cart
Toggle navigation
Peptides and Proteins
Amyloid-Beta
Recombinant Human Amyloid-Beta and Variants
Synthetic Amyloid-Beta and Variants
Isotope Labeled Amyloid-Beta (13C and/or 15N)
Alpha-Synuclein
Recombinant Human Alpha-Synuclein Wild Type
Recombinant Human Alpha-Synuclein Variants
Recombinant Mouse Alpha-Synuclein
Isotope Labeled Alpha-Synuclein (13C and/or 15N)
Transthyretin
Recombinant Human Transthyretin and Variants
Isotope Labeled Transthyretin (13C and/or 15N)
Apolipoprotein E
Recombinant Human Apolipoprotein E2, E3 and E4 (full-length)
Recombinant Variants of Human Apolipoprotein E
Isotope Labeled Apolipoprotein E2, E3 and E4
Recombinant Non-Human Apolipoprotein E and Variants
Tau
Amylin/IAPP
Custom Synthetic Peptides
Peptide modifications
Catalog Antibodies
Amyloid-Beta Antibodies
Alpha-Synuclein Antibodies
Transthyretin antibodies
Human SOD 1 Antibodies
Services
Cryopreservation/Cell banking
13C and 15N-Isotope Labeling
Assay Design and Analysis
Custom protein expression/purification
Antigen design for immunization
Short immunopeptides + KLH coupling
Chimeric Proteins - the next generation of antigens
Publications
Support
General questions
Order and Payment
Shipping
Privacy Policy
About us
Menu
Search
Publications
Publications with AlexoTech
Explore research using AlexoTech products.
Transthyretin stabilizer therapy increases naturally-occurring antibodies in ATTR cardiomyopathy
Shared Binding Properties Between a Therapeutic Antibody and Anti-Transthyretin Antibodies From Transthyretin Cardiac Amyloidosis Patients: Translational Implications for Future Clinical Trials
Silica-Embedded Proteins Enable Higher Yield and Atomic Ion Detection in Deep-UV Laser-Assisted Atom Probe Tomography
Tear fluid as a novel specimen for detection of alpha-synuclein seeding activity in Parkinson’s disease
Amyloid beta pathology induces astrocytic pTDP-43 mislocalization and disrupts TDP-43-regulated cryptic exon transcripts
The Co(II) ion binds to the N-terminal region of amyloid-beta (Aβ) peptides and modulates Aβ aggregation
Alzheimer’s Aβ catalyzes Tau phase separation and aggregation via early nanocluster solubilization
Lysozyme as an amyloid fibril protein together with transthyretin in the ligamentum flavum in association with lumbar spinal stenosis
Single-molecule imaging of small aggregates of IAPP in type 2 diabetes serum with rationally-designed antibody-like scaffolds
APOE isotype-dependent regulation of IgG and IgA levels against different IAPP epitopes
Binding of ApoE Isoforms to Aβ Peptides and Effects on Their Fibrillization
Disrupted glutathione homeostasis in the pathogenesis of TTR-V30M amyloidosis
Misfolding of transthyretin in vivo is controlled by the redox environment and macromolecular crowding
Cholesterol modulates vesicle clustering mediated by alpha-synuclein in a nonlinear fashion
Binding of Hg(I) and Hg(II) Ions to Amyloid-Beta (Aβ) Peptide Variants Affect their Structure and Aggregation
Biophysical analysis of angiotensin II and amyloid-β cross-interaction in aggregation and membrane disruption
Molecular interactions, structural effects, and binding affinities between silver ions (Ag+) and amyloid beta (Aβ) peptides
Correlative light and electron microscopy imaging of proteinaceous deposits in cell cultures and brain tissues
Recruitment of apolipoprotein E facilitates Herpes simplex virus 1 attachment and release
A Step-By-Step Protocol for Correlative Light and Electron Microscopy Imaging of Proteinaceous Deposits in Cultured Cells and Human Brain Tissues
Transthyretin Levels and Instability in Alzheimer’s Disease: Correlations with AD Biomarkers in a Cohort Study
APOE3ch alters microglial response and suppresses Aβ-induced tau seeding and spread.
Accumulation of alpha-synuclein pathology in the liver exhibits post-translational modifications associated with Parkinson’s disease
Structural conversion of the spidroin C-terminal domain during assembly of spider silk fibers
Back to top